PHIO
Price
$2.43
Change
+$0.08 (+3.40%)
Updated
Oct 8, 04:56 PM (EDT)
Capitalization
13.86M
QLGN
Price
$4.95
Change
-$0.08 (-1.59%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
9.9M
Interact to see
Advertisement

PHIO vs QLGN

Header iconPHIO vs QLGN Comparison
Open Charts PHIO vs QLGNBanner chart's image
Phio Pharmaceuticals
Price$2.43
Change+$0.08 (+3.40%)
Volume$200
Capitalization13.86M
Qualigen Therapeutics
Price$4.95
Change-$0.08 (-1.59%)
Volume$690
Capitalization9.9M
PHIO vs QLGN Comparison Chart in %
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHIO vs. QLGN commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHIO is a Hold and QLGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (PHIO: $2.42 vs. QLGN: $4.87)
Brand notoriety: PHIO and QLGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHIO: 71% vs. QLGN: 12%
Market capitalization -- PHIO: $13.86M vs. QLGN: $9.9M
PHIO [@Biotechnology] is valued at $13.86M. QLGN’s [@Biotechnology] market capitalization is $9.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHIO’s FA Score shows that 0 FA rating(s) are green whileQLGN’s FA Score has 2 green FA rating(s).

  • PHIO’s FA Score: 0 green, 5 red.
  • QLGN’s FA Score: 2 green, 3 red.
According to our system of comparison, QLGN is a better buy in the long-term than PHIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHIO’s TA Score shows that 6 TA indicator(s) are bullish while QLGN’s TA Score has 5 bullish TA indicator(s).

  • PHIO’s TA Score: 6 bullish, 4 bearish.
  • QLGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PHIO is a better buy in the short-term than QLGN.

Price Growth

PHIO (@Biotechnology) experienced а 0.00% price change this week, while QLGN (@Biotechnology) price change was -18.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.02%. For the same industry, the average monthly price growth was +18.92%, and the average quarterly price growth was +86.47%.

Industries' Descriptions

@Biotechnology (+9.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHIO($13.9M) has a higher market cap than QLGN($9.9M). QLGN has higher P/E ratio than PHIO: QLGN (0.77) vs PHIO (0.01). PHIO YTD gains are higher at: 34.444 vs. QLGN (15.677). QLGN has higher annual earnings (EBITDA): -6.28M vs. PHIO (-7.45M). PHIO has more cash in the bank: 10.8M vs. QLGN (332K). PHIO has less debt than QLGN: PHIO (0) vs QLGN (3.62M). PHIO (0) and QLGN (0) have equivalent revenues.
PHIOQLGNPHIO / QLGN
Capitalization13.9M9.9M140%
EBITDA-7.45M-6.28M118%
Gain YTD34.44415.677220%
P/E Ratio0.010.772%
Revenue00-
Total Cash10.8M332K3,253%
Total Debt03.62M-
FUNDAMENTALS RATINGS
PHIO vs QLGN: Fundamental Ratings
PHIO
QLGN
OUTLOOK RATING
1..100
836
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4735
P/E GROWTH RATING
1..100
631
SEASONALITY SCORE
1..100
790

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QLGN's Valuation (24) in the null industry is in the same range as PHIO (50) in the Biotechnology industry. This means that QLGN’s stock grew similarly to PHIO’s over the last 12 months.

QLGN's Profit vs Risk Rating (100) in the null industry is in the same range as PHIO (100) in the Biotechnology industry. This means that QLGN’s stock grew similarly to PHIO’s over the last 12 months.

PHIO's SMR Rating (99) in the Biotechnology industry is in the same range as QLGN (100) in the null industry. This means that PHIO’s stock grew similarly to QLGN’s over the last 12 months.

QLGN's Price Growth Rating (35) in the null industry is in the same range as PHIO (47) in the Biotechnology industry. This means that QLGN’s stock grew similarly to PHIO’s over the last 12 months.

QLGN's P/E Growth Rating (1) in the null industry is somewhat better than the same rating for PHIO (63) in the Biotechnology industry. This means that QLGN’s stock grew somewhat faster than PHIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHIOQLGN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPRO2.280.12
+5.56%
Spero Therapeutics
INBS1.140.05
+5.05%
Intelligent Bio Solutions
BBBY11.140.11
+1.00%
Bed Bath & Beyond Inc
WST267.931.96
+0.74%
West Pharmaceutical Services
BANC17.710.10
+0.57%
Banc of California

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been loosely correlated with MTNB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PHIO jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
+2.98%
MTNB - PHIO
50%
Loosely correlated
-1.06%
TPST - PHIO
49%
Loosely correlated
+2.23%
AZTR - PHIO
49%
Loosely correlated
+1.99%
KAPA - PHIO
46%
Loosely correlated
+7.38%
SLRX - PHIO
41%
Loosely correlated
-8.85%
More

QLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QLGN has been loosely correlated with MBX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if QLGN jumps, then MBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QLGN
1D Price
Change %
QLGN100%
-3.18%
MBX - QLGN
38%
Loosely correlated
+0.38%
NEVPF - QLGN
35%
Loosely correlated
N/A
NTLA - QLGN
34%
Loosely correlated
+19.72%
KOD - QLGN
32%
Poorly correlated
+1.62%
PHIO - QLGN
32%
Poorly correlated
+2.98%
More